Gujarat Themis Biosyn Ltd.

383.00 -1.65 ▼-0.4%

16 April 2024, 12:53:00 PM
Volume: 23,859

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.gtbl.in
Market Cap 2,796.78 Cr.
Enterprise Value(EV) 2,789.56 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 7.57 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 50.88 Trailing Twelve Months Ending 2023-12
Industry PE 40.96 Trailing Twelve Months Ending 2023-12
Book Value / Share 26.29 Trailing Twelve Months Ending 2023-12
Price to Book Value 14.64 Calculated using Price: 385.00
Dividend Yield 0.28 Period Ending 2023-03
No. of Shares Subscribed 7.26 Cr. 72,643,510 Shares
FaceValue 1
About Gujarat Themis Biosyn Ltd.
Gujarat Themis Biosyn Ltd, established in 1981, is a biotech and synthetic product manufacturing company, having plants at Vapi, Hyderabad, with group turnover of over $ 40 million. It has EDMFs, available and WHO approved plants.The company has world-wide exports to satisfied customers, having customised facility for all products.The company’s principal activity is to manufacture and distributes pharmaceuticals bulk drugs called rifampicin produced by fermentation process. The company's products include preparations of active pharmaceutical ingredient rifampicin and lovastatin. The company exports its products to Europe and the United States.

Gujarat Themis Biosyn Ltd. Delivery

Delivered Qty
Traded Qty

Gujarat Themis Biosyn Ltd. Performance

1 Day
-0.43%
1 Week
-3.16%
1 Month
+3.71%
3 Month
+15.69%
6 Month
+74.69%
1 Year
+159.19%
2 Year
+364.13%
5 Year
+5175.48%
10 Year
+16197.87%

Gujarat Themis Biosyn Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 0 302.71 72.63 38.06 41.85 77.99 53.82 50.35 45.92
Return on Capital Employed (%) 113.74 80.38 54.67 42.22 44.88 85.96 67.89 67.91 61.53
Return on Assets (%) 29.88 31.5 24.25 18.45 24.07 45.62 35.65 37.08 35.81

Gujarat Themis Biosyn Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds -1 4 8 12 19 42 70 103 149 178
Non Curr. Liab. 6 2 1 0 1 5 2 2 2 3
Curr. Liab. 10 9 12 8 13 24 26 32 36 16
Minority Int.
Equity & Liab. 15 15 21 20 33 71 98 137 187 197
Non Curr. Assets 11 11 13 13 25 35 25 44 105 149
Curr. Assets 3 3 8 8 8 36 73 93 81 48
Misc. Exp. not W/O
Total Assets 15 15 21 20 33 71 98 137 187 197

Gujarat Themis Biosyn Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 31 33 36 39 41 85 91 115 149 156
Other Income 0 0 0 0 2 2 3 4 6 4
Total Income 32 33 36 39 43 87 94 119 155 161
Total Expenditure -25 -27 -30 -33 -34 -53 -50 -57 -75 -83
PBIDT 6 6 6 6 10 34 44 62 80 77
Interest 0 0 0 0 0 -1 -1 -1 0 0
Depreciation -1 -1 -1 -1 -1 -1 -2 -2 -3 -3
Taxation -1 -1 -2 -8 -11 -15 -20 -19
Exceptional Items
PAT 5 5 4 4 6 24 30 44 58 55
Adjusted EPS 1 1 1 1 1 3 4 6 8 8

Gujarat Themis Biosyn Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 4 3 4 3 6 1 1 11 40 40
Cash Fr. Inv. 0 0 -1 -3 -1 -6 -3 -2 -30 -20
Cash Fr. Finan. -3 -3 -3 0 -4 5 2 -5 -14 -13
Net Change 1 -1 0 0 1 0 0 3 -4 6
Cash & Cash Eqvt 1 0 0 0 1 1 1 4 0 6

Gujarat Themis Biosyn Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 74.99 74.99 74.99 74.99 74.99 74.99 74.99 74.99 70.86
Public 25.01 25.01 25.01 25.01 25.01 25.01 25.01 25.01 29.14
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 3.30
No. of Shareholders (in Lacs)

Gujarat Themis Biosyn Ltd. Announcements

Wed, 10 Apr 2024
Compliance Certificate Under Regulation 7(3) Of The SEBI (LODR) Regulations 2015 For The Financial Year Ended 31St March 2024.
Please find our certificate on the captioned subject.
Mon, 08 Apr 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Please find our intimation on the captioned subject.
Wed, 27 Mar 2024
Closure of Trading Window
Please find our intimation on the captioned subject.

Gujarat Themis Biosyn Ltd. Technical Scans

Mon, 15 Apr 2024
Opening at Low Opening at Low
Making Lower Lows for 3 days Making Lower Lows for 3 days
Close Within 52 Week High Zone Close Within 52 Week High Zone
Making Lower Lows for 2 Days Making Lower Lows for 2 Days
High Increase in 3 Months High Increase in 3 Months

Gujarat Themis Biosyn Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 369,773.51 1,531.05 -0.6%
Cipla Ltd. 111,517.58 1,383.20 +0.1%
Dr. Reddy's Laboratories Ltd. 100,257.78 6,038.00 +0.4%
Divi's Laboratories Ltd. 98,636.18 3,748.80 +0.9%
Zydus Lifesciences Ltd. 94,082.88 950.30 +1.6%
Mankind Pharma Ltd. 90,721.26 2,280.55 +0.6%
Apollo Hospitals Enterprise Ltd. 90,631.78 6,275.30 -0.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 41.52 1,531.05 -0.6%
Cipla Ltd. Consolidated 2023-12 30.07 1,383.20 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.18 6,038.00 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-12 71.32 3,748.80 +0.9%
Zydus Lifesciences Ltd. Consolidated 2023-12 31.64 950.30 +1.6%
Mankind Pharma Ltd. Consolidated 2023-12 52.53 2,280.55 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 114.82 6,275.30 -0.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.93 1,531.05 -0.6%
Cipla Ltd. Consolidated 2023-12 4.31 1,383.20 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.73 6,038.00 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-12 7.57 3,748.80 +0.9%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.99 950.30 +1.6%
Mankind Pharma Ltd. Consolidated 2023-12 10.21 2,280.55 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.42 6,275.30 -0.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,531.05 -0.6%
Cipla Ltd. Consolidated 2023-03 0.02 1,383.20 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,038.00 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,748.80 +0.9%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 950.30 +1.6%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,280.55 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,275.30 -0.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,531.05 -0.6%
Cipla Ltd. Consolidated 2023-03 12.85 1,383.20 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,038.00 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,748.80 +0.9%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 950.30 +1.6%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,280.55 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,275.30 -0.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,531.05 -0.6%
Cipla Ltd. Consolidated 2023-03 12.85 1,383.20 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,038.00 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,748.80 +0.9%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 950.30 +1.6%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,280.55 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,275.30 -0.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,531.05 -0.6%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,383.20 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,038.00 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,748.80 +0.9%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 950.30 +1.6%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,280.55 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,275.30 -0.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,531.05 -0.6%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,383.20 +0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,038.00 +0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,748.80 +0.9%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 950.30 +1.6%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,280.55 +0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,275.30 -0.4%

Gujarat Themis Biosyn Ltd. FAQ's

What is Guj. Themis Biosyn share price?

Can I buy Guj. Themis Biosyn shares now?

What is the Dividend Yield of Guj. Themis Biosyn?

What is the Market Cap of Guj. Themis Biosyn?

What are the key metrics to analyse Guj. Themis Biosyn?

What is the 52 Week High and Low of Guj. Themis Biosyn?

What is the trend of Guj. Themis Biosyn share price?